Quantcast

Latest Gilead Sciences Inc. Stories

2011-07-12 06:00:00

PITTSBURGH and HYDERABAD, India, July 12, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced an expanded licensing agreement between Gilead Sciences Inc. and Mylan's Matrix Laboratories Limited. Matrix has licensed the rights to produce and market generic versions of three Gilead HIV/AIDS therapies, if and when they receive regulatory approval. The Gilead products, which are currently in late-stage clinical development, include: Elvitegravir, an investigational integrase...

2011-06-06 08:00:00

VANCOUVER, British Columbia, June 6, 2011 /PRNewswire-Asia/ -- Insiderslab.com released new critical reports that disclosed the favorable insider trades found in GT Solar, American Tower, Brocade, JDS Uniphase, Limited Brands, & Gilead Sciences today. It is a smart investment strategy by researching or picking stocks start from the larger size transaction. Obviously, the more money is logged on to a single insider trade, the more significant that trade will be. On another aspect, the...

2011-05-26 12:00:00

Public and Private Sectors Join to Get Out the Word about HIV Testing Five-City Concert Series, Free HIV Testing Events, Special Programming and More NEW YORK, May 26, 2011 /PRNewswire-USNewswire/ -- Greater Than AIDS and GYT: Get Yourself Tested, two leading national campaigns committed to reducing the spread of HIV and other sexually transmitted diseases, are teaming up for a second year to encourage Americans to get tested and know their status. In the lead up to National HIV Testing...

2011-05-04 09:45:00

WESTMINSTER, Colo., May 4, 2011 /PRNewswire/ -- Plato BioPharma, Inc. (PBI) and Gilead Sciences, Inc. will be jointly presenting a thematic poster at the "Novel Therapeutics in Pulmonary Fibrosis" session at the 2011 American Thoracic Society (ATS) International Conference in Denver, Colorado on May 18, 2011. The poster entitled Differing Effects of Ambrisentan and Bosentan on Pulmonary Fibrosis and Lung Mechanics Following Bleomycin Instillation will be presented by John Liles, PhD of...

2011-04-22 00:00:30

AIDS Healthcare Foundation (AHF) launched a campaign today to educate employees and neighbors of Gilead Sciences, Inc. over the high price of its key AIDS drugs, such as Atripla, which are putting a strain on state cash-strapped AIDS Drug Assistance Programs (ADAPs). The campaign includes postcards sent to residents of neighborhoods surrounding the company's headquarters in Foster City, California"”including Foster City, Hillsborough, Atherton, Redwood City and El Granada in San Mateo...

9dd9ef066dd9141be31d69f8f24ae0571
2011-04-18 13:56:36

Researchers are stopping tests of a daily pill to prevent infection with the AIDS virus in thousands of African women. The study was stopped because partial results show no signs that the drug is preventing the virus. The study found that women taking Truvada, made by Gilead Sciences Inc., are just as likely to get HIV as other women who have been given dummy pills.  Researchers said that even if the study were to continue it would not be able to determine whether the pills help prevent...

2010-10-08 09:00:00

VANCOUVER, Canada, Oct. 8 /PRNewswire-Asia/ -- Insiderslab.com issues new research reports that highlight large insider trades found in Marriott, BMC, Brigham Exploration, Tellabs, Range Resources, & Gilead Sciences. Read our research reports with Interactive Insider Trading Charts and Insider Trade Statistics below. Insiders refer to company Top Executive Officers (CEOs, CFOs, COOs) and Directors who are involved in making critical corporate decisions. The insider trades made...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.